aTyr Pharma Inc
General ticker "LIFE" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $113.6M
aTyr Pharma Inc follows the US Stock Market performance with the rate: 24.4%.
Estimated limits based on current volatility of 3.3%: low 1.49$, high 1.60$
Factors to consider:
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term predictions were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 predicted range: [0.99$, 2.77$]
- 2024-12-30 to 2025-12-30 predicted range: [1.55$, 3.85$]
Financial Metrics affecting the LIFE estimates:
- Negative: Non-GAAP EPS of -0.96 <= 0.09
- Negative: Operating Income to Revenue ratio of -0.99 <= 0.01
- Negative: Operating Cash Flow per share of -0.62 <= 0.21
- Negative: negative Net Income
- Negative: Industry Operating Cash Flow per share (median) of -1.54 <= 0.29
Short-term LIFE quotes
Long-term LIFE plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $10.39MM | $0.35MM |
| Operating Expenses | $34.02MM | $56.79MM | $55.27MM |
| Operating Income | $-34.02MM | $-46.40MM | $-54.92MM |
| Non-Operating Income | $0.24MM | $1.06MM | $4.52MM |
| Interest Expense | $0.00MM | $1.70MM | $0.00MM |
| R&D Expense | $23.26MM | $42.81MM | $42.29MM |
| Income(Loss) | $-33.78MM | $-45.34MM | $-50.40MM |
| Taxes | $0.00MM | $0.00MM | $-0.01MM |
| Profit(Loss) | $-33.78MM | $-45.34MM | $-50.39MM |
| Stockholders Equity | $109.13MM | $71.28MM | $90.66MM |
| Assets | $115.54MM | $95.79MM | $122.07MM |
| Operating Cash Flow | $-33.08MM | $-41.89MM | $-33.22MM |
| Investing Cash Flow | $-91.57MM | $47.24MM | $-20.13MM |
| Financing Cash Flow | $110.03MM | $5.45MM | $66.23MM |
| Earnings Per Share* | $-1.70 | $-1.56 | $-0.94 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.